Enteral Nutrition Market Report: Size, Share and Outlook by 2031

The enteral nutrition market is projected to expand from US$ 8,276.93 million in 2022 to US$ 13,204.19 million by 2030, reflecting a compound annual growth rate (CAGR) of 6.0% during the period from 2022 to 2030. This growth is primarily driven by an increase in the 

incidence of gastrointestinal disorders, alongside rising cases of malnutrition and premature births.

There is a notable increase in the demand for products that enable consumers to take charge of their health proactively, particularly those tailored to specific requirements related to energy, immunity, and disease management. Nutritional needs vary significantly depending on the illness. The functionality and specialized formulations of enteral and parenteral products complement existing treatments, providing a more targeted and effective approach to patient care. The formulations of macro and micronutrients in enteral and parenteral nutrition are adapted to address various health conditions, including cancer and gastrointestinal disorders. Furthermore, pharmaceutical companies are developing enteral and parenteral nutrition solutions with personalized (patient-specific) components. For instance, Impact, a product from Nestle, is a clinically validated nutritional option designed for patients undergoing major elective surgeries, aimed at minimizing postoperative complications, shortening hospital stays, and enhancing clinical outcomes. The initiatives by companies to create such tailored formulations will significantly drive the growth of the enteral nutrition sector.

Moreover, numerous organizations are actively promoting awareness regarding the benefits of specific nutritional formulations. The American Society for Parenteral and Enteral Nutrition (ASPEN), a prominent medical professional organization in the United States, comprises dietitians, pharmacists, physicians, nurses, nurse practitioners, scientists, students, and other health professionals dedicated to delivering clinical nutrition to patients and educating them. Such initiatives are expected to bolster the growth of the enteral nutrition market in the coming years.

Additionally, the increasing trend of consumers opting for plant-based diets is fueling the demand for plant-based nutritional products globally. Many individuals are becoming more intolerant to artificial or synthetically derived ingredients, which can lead to adverse reactions. Consequently, products with fewer ingredients are often preferred. The Innova Consumer Survey 2020 highlighted that health, dietary variety, sustainability, and taste are key factors influencing the choice of plant-based alternatives. According to Abbott, this trend also extends to consumers and patients who rely on tube feeding. The American Medical Association has urged healthcare facilities to offer plant-based meal options to enhance patient health. States such as California, New York, and the District of Columbia have mandated that hospitals provide healthy, plant-based meals to all patients. Companies within the enteral nutrition market are optimistic that the growing emphasis on healthy eating will lead to a preference for more nutritious products.
Thus, functional, patient-centric formulations and plant-based nutrition products are emerging as significant trends in the enteral nutrition market.

Insights Based on Age Groups

The enteral nutrition market is segmented by age group into adult and pediatric categories. In 2022, the adult segment dominated the market share. However, the pediatric segment is projected to experience a CAGR of 6.8% from 2022 to 2030. Standard tube-feeding formulas are typically designed for adults with normal digestion and often include additional ingredients like fibers to enhance digestive health and bowel management. Similar to standard formulas, peptide-based formulas are nutritionally complete but differ in that some of their components, such as proteins, are hydrolyzed into smaller units for easier digestion and absorption. This characteristic makes peptide formulas particularly suitable for adults facing digestive challenges, including short bowel syndrome, inflammatory bowel disease, malabsorption, and cystic fibrosis. Specialized enteral formulas tailored for adults with specific nutritional requirements, such as those with diabetes, kidney failure, respiratory issues, or liver diseases, are also available. A variety of medical nutrition formulas for adults can be found in the market, with key ingredients including lipid emulsions, dextrose, amino acids, vitamins, electrolytes, minerals, and trace elements. These components are essential for preventing villous atrophy and enhancing the gut's local immune function. Elecare by Ross is an example of a tube-feeding formula approved for adult use, indicated for managing conditions like protein maldigestion, malabsorption, severe food allergies, short-bowel syndrome, and eosinophilic gastrointestinal disorders, among others.
The report on the enteral nutrition market utilizes data from primary and secondary sources, including the British Association for Parenteral and Enteral Nutrition, the Centers for Disease Control and Prevention (CDC), and the Global Burden of Disease Study.